Pharmafile Logo

OPEN Health at ECRD 2020

May 14, 2020 | #ECRD2020, rare, virtualevents 

Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.

Our Director of Rare Disease, Gavin Jones, is looking forward to spending the next two days at the #ECRD2020 congress.  It’s going to be a busy few days with highlights for Gavin being sessions on achieving faster diagnosis, innovation with advanced therapies and the future of specialised services.   He will report back so watch this space.

To keep sustained today Gavin is snacking on fruit, chocolate and cold brew tea (who has time to boil a kettle?). He is also delighted that this is the first time he has been able to bring his beloved Eddie to a congress!

If you are there, send Gavin a chat message through the congress platform to connect.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

OPEN Health Appoints Richard Jones as President for Evidence & Access

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...

How digital health is changing the relationship between patients and health providers | OPEN Health

The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes